The hepatitis C virus infects more than 170 million people worldwide. Many of the HCV deaths have been a result of drug resistance. It is essential for researchers to continue to modify the molecules to create a greater variety of drug analogues, and in doing so create one that is the solution to the HCV epidemic. HCV drug analogs that lack a side chain are less hindered and more adaptable in fighting the mutant virus; drugs of this molecular form should be focused on to produce an optimal drug response to the virus.

• This report represents the work of one or more WPI undergraduate students submitted to the faculty as evidence of completion of a degree requirement. WPI routinely publishes these reports on its website without editorial or peer review.

Creator

• Foust, Kathleen Suzanne

Publisher

• Worcester Polytechnic Institute

Identifier

• E-project-042612-141254

Advisor

• Heilman, Destin

Year

• 2012

Date created

• 2012-04-26

Resource type

• Major Qualifying Project

Major

• Chemistry

Rights statement

• In Copyright